{"version":"1.0","type":"link","title":"Patient-Reported Symptoms and Quality of Life With Sacituzumab Govitecan Versus Docetaxel in Metastatic NSCLC: The Phase 3, Randomized EVOKE-01 Trial.","author_name":"Reinmuth N 외","author_url":"https://prs-insight.online/author/Reinmuth%20N","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/97740","thumbnail_width":1200,"thumbnail_height":630}